Capitol HillNCI NCI’s Letai gets softball questions from Senate appropriators at an otherwise contentious hearing May 22, 2026Vol.52 No.20By Jacquelyn Cobb
Capitol Hill USPSTF leaders John Wong and Esa Davis fired by Kennedy, leaving the panel rudderless May 22, 2026Vol.52 No.20By Claire Marie Porter
Guest Editorial UMGCCC neuro-oncologist navigates the reality of his father’s pancreatic cancer May 22, 2026Vol.52 No.20By Haroon Ahmad
Cancer History ProjectFreePodcast “Backwater to Blockbuster” chronicles the previously untold story of the explosive growth of St. Jude Children’s Research HospitalIn a conversation with Deborah Doroshow, co-authors Chuck Sherr and Bill Evans discuss their collaborative writing process May 15, 2026Vol.52 No.19By Claire Marie Porter
FDA clears fruit-flavored vapes, relaxes enforcement on black-market products with pending premarket applicationsCritics say policies clear the way for major tobacco companies to enter fruit-flavored vape market May 15, 2026Vol.52 No.19By Sara Willa Ernst
Regulatory News After a year-long reign over tumult at FDA, Makary heads for the exitFruit-flavored e-cigs were the final blow for the commissioner May 15, 2026Vol.52 No.19By Claire Marie Porter
Sponsored How City of Hope is turning microbiome science into better cancer care May 15, 2026Vol.52 No.19By Marcel van den Brink and Robert Jenq
Sponsored Houston Methodist researchers identify B cells as driver of immunotherapy resistance in liver cancer May 15, 2026Vol.52 No.19By Dan G. Duda
Regulatory News Breakthrough Therapy designation, ASCO plenary, and NEJM publication notwithstanding, breast cancer drug camizestrant gets a No from ODAC May 08, 2026Vol.52 No.18By Jacquelyn Cobb
Vinay Prasad’s CV inaccurately claims past membership on the President’s Cancer Panel May 08, 2026Vol.52 No.18By Paul Goldberg
